LAVA THERAPEUTICS NV (LVTX) Stock Cash Flow
NASDAQ:LVTX - Nasdaq - NL0015000AG6 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.33M | -41.70M | -31.66M | -45.19M | -15.46M | |||
| Depreciation Amortization | 1.04M | 1.28M | 780.00K | 560.00K | 460.00K | |||
| Change In Working Capital | -5.46M | -2.83M | 34.11M | 10.84M | 4.73M | |||
| Other non cash items | 3.50M | 4.27M | 810.00K | 5.15M | 960.00K | |||
| OPERATING CASH FLOW | -28.26M | -38.97M | 4.04M | -28.65M | -9.31M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -730.00K | -590.00K | -760.00K | -500.00K | |||
| Other Investing Activity | -7.16M | -16.91M | 9.93M | -42.78M | 0.00 | |||
| INVESTING CASH FLOW | -7.18M | -17.64M | 9.35M | -43.55M | -500.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -570.00K | -571.00K | 270.00K | 340.00K | 1.79M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 20.00K | 89.02M | -4.85M | |||
| Other Financing Activity | N/A | 0.00 | N/A | 61.80M | 22.03M | |||
| FINANCING CASH FLOW | -543.00K | -571.00K | 280.00K | 151.16M | 18.97M | |||
| Exchange Rate Effect | 285.00K | 1.08M | -4.21M | -3.92M | -680.00K | |||
| CHANGE IN CASH | -35.70M | -56.10M | 9.46M | 75.04M | 8.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.26M | -38.97M | 4.04M | -28.65M | -9.31M | |||
| Capital Expenditure | N/A | -730.00K | -590.00K | -760.00K | -500.00K | |||
| FREE CASH FLOW | -28.28M | -39.70M | 3.45M | -29.41M | -9.81M | |||
All data in USD